Outside the United States, Lucentis is approved in more than 120 countries to treat adult patients with wet AMD, and for the treatment of visual impairment due to DME, due to macular edema secondary ...

We show that intravitreal Bevacizumab treatment for macular edema induced by BRVO leads to a fast and significant improvement of visual acuity and a concurrent decrease of CRT. Similar results ...

[10,46,47] Ranibizumab and dexamethasone IVT implant have recently been approved for treatment of visual impairment due to macular oedema secondary to both BRVO and CRVO. It is therefore relevant ...

Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR ...

Background/aims To describe clinical and multimodal imaging features in a cohort of choroidal macrovessels. Methods Demographics and multimodal imaging features of 16 eyes of 13 patients with ...

Here's what macular degeneration is, what causes it and how you can expect it to be treated if it affects you or a loved one. Macular degeneration, also known as age-related macular degeneration ...

Bravo Mining Corp. (TSXV: BRVO) (OTCQX: BRVMF), ("Bravo" or the "Company") has received assay results from the final seven diamond drill holes ("DDH") in the Central Sector of its 100% owned ...

Please provide your email address to receive an email when new articles are posted on . The RapidAI software successfully processed and identified more eligible large vessel occlusion cases vs ...